A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome
Latest Information Update: 20 May 2024
At a glance
- Drugs NTX-001 Neuraptive Therapeutics (Primary)
- Indications Peripheral nerve injuries
- Focus Adverse reactions
- 10 Aug 2023 Status changed from not yet recruiting to recruiting.
- 15 May 2023 Planned initiation date changed from 1 Apr 2023 to 1 Jun 2023.
- 13 Mar 2023 Planned initiation date changed from 1 Feb 2023 to 1 Apr 2023.